Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
about
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dual therapy with peg-interfer ...... Is there still an indication?
@en
type
label
Dual therapy with peg-interfer ...... Is there still an indication?
@en
prefLabel
Dual therapy with peg-interfer ...... Is there still an indication?
@en
P2093
P50
P1476
Dual therapy with peg-interfer ...... Is there still an indication?
@en
P2093
Alfonso Galeota Lanza
Erika Poggiali
Gianluca Forni
Vito Di Marco
on behalf ITHACA (Italy for THAalassemia, hepatitis C Advances) Group
P304
P356
10.1016/J.DLD.2016.02.004
P577
2016-02-21T00:00:00Z